We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

57 hedge funds and large institutions have $109M invested in Annovis Bio in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

371% more capital invested

Capital invested by funds: $23.1M → $109M (+$85.8M)

371% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 7

84% more funds holding

Funds holding: 31 → 57 (+26)

4.01% more ownership

Funds ownership: 12.01% → 16.01% (+4%)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

Holders
57
Holders Change
+26
Holders Change %
+83.87%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
10
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Voloridge Investment Management
Voloridge Investment Management
Florida
+$4.73M
2
BlackRock
BlackRock
New York
+$4.67M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.81M
4
KCM
Knoll Capital Management
Florida
+$1.81M
5
Morgan Stanley
Morgan Stanley
New York
+$1.39M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$4.15M
2
Renaissance Technologies
Renaissance Technologies
New York
-$555K
3
SIAP
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
-$513K
4
LIG
Lokken Investment Group
Delaware
-$486K
5
BFM
Boothbay Fund Management
New York
-$472K
Name Holding Trade Value Shares
Change 		Change in
Stake
WSFS
26
Wilmington Savings Fund Society
Delaware
$804K -$243K -5,250 -36%
Northern Trust
27
Northern Trust
Illinois
$779K +$77.3K +1,673 +23%
JP Morgan Chase
28
JP Morgan Chase
New York
$687K +$371K +8,024 New
PCM
29
Prelude Capital Management
New York
$665K -$151K -3,278 -30%
RAM
30
Redmond Asset Management
Virginia
$663K +$358K +7,750 New
SAM
31
Silvercrest Asset Management
New York
$616K – – –
AWM
32
Absher Wealth Management
North Carolina
$542K +$292K +6,329 New
RWM
33
RKL Wealth Management
Pennsylvania
$428K -$231K -5,000 -50%
WANY
34
Wealthspire Advisors (New York)
New York
$428K -$231K -5,000 -50%
Brown Advisory
35
Brown Advisory
Maryland
$389K -$134K -2,900 -39%
CSS
36
Cubist Systematic Strategies
Connecticut
$386K +$208K +4,508 New
Deutsche Bank
37
Deutsche Bank
Germany
$374K +$202K +4,367 New
BCB
38
Brian C. Broderick
$342K +$185K +4,000 New
Commonwealth Equity Services
39
Commonwealth Equity Services
Massachusetts
$339K +$183K +3,964 New
LPL Financial
40
LPL Financial
California
$331K +$179K +3,868 New
Millennium Management
41
Millennium Management
New York
$307K +$166K +3,587 New
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$257K +$139K +3,000 New
Two Sigma Advisers
43
Two Sigma Advisers
New York
$257K +$139K +3,000 New
CLCM
44
Crawford Lake Capital Management
New Jersey
$237K +$128K +2,764 New
BLAM
45
Bourne Lent Asset Management
New York
$231K +$125K +2,700 New
GPFA
46
Game Plan Financial Advisors
Ohio
$231K +$125K +2,700 New
VEA
47
Virtus ETF Advisers
New York
$215K +$116K +2,518 New
BRWA
48
B. Riley Wealth Advisors
Florida
$208K +$112K +2,430 New
Osaic Holdings
49
Osaic Holdings
Arizona
$149K -$114K -2,458 -59%
UBS Group
50
UBS Group
Switzerland
$100K +$54K +1,168 New
1
2
3

ANVS Hedge Fund Activity: Q2 2021 in Review

57 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q2 2021, worth a combined $109M — up 371% from $23.1M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ANVS positions and 7 closed out — a net gain of 26 holders — while 10 added to existing stakes and 12 trimmed.

The largest buyer was Voloridge Investment Management, opening a new position worth an estimated $4.73M. The largest seller was Ikarian Capital, cutting an estimated $4.15M.

  • 57 institutional investors held Annovis Bio (ANVS) as of Q2 2021, up from 31 in Q1 2021.
  • Funds reported $109M of Annovis Bio stock for Q2 2021, up 371% quarter-over-quarter.
  • 33 funds opened new Annovis Bio positions in Q2 2021 and 7 closed out, a net change of +26 holders.
  • The largest Annovis Bio buyer in Q2 2021 was Voloridge Investment Management, an estimated $4.73M added.
  • The largest Annovis Bio seller in Q2 2021 was Ikarian Capital, an estimated $4.15M sold.

Based on aggregated 13F filings for Q2 2021.